Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1985-10-04
1987-09-08
Terapane, John F.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 422 61, A61K 4300, A61K 4902, A61K 4900, G01N 3315
Patent
active
046923241
ABSTRACT:
A composition containing stannous chloride and potassium perchlorate is suitable for oral administration to a patient for tinning red blood cells of the patient in vivo prior to labeling the red blood cells with radioactive .sup.99m Tc. The composition is useful for preparing a patient for blood pool imaging, and especially for carrying out equilibrium gated cardiac imaging.
REFERENCES:
patent: 4075314 (1978-02-01), Wolfangel et al.
patent: 4113850 (1978-09-01), Benes
patent: 4300569 (1981-11-01), Bonneau
patent: 4342740 (1982-08-01), Narra et al.
Patel et al, J. Nuclear Medicine, 20, pp. 877-881, 1979.
Prince et al, J. Nuclear Medicine, 21, pp. 763-766, 1980.
Terapane John F.
Thomas J. E.
LandOfFree
Method and composition for in vivo radiolabeling of red blood ce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for in vivo radiolabeling of red blood ce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for in vivo radiolabeling of red blood ce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157466